Company Overview and News

 
Covanta’s green tech is a hit in Europe — is the U.S. next? - MarketWatch

2018-04-20 marketwatch
Covanta has six projects lined up in Europe, where the production of electricity via trash burning is a popular technology
Upvote Downvote

 
ISS backs Cation Capital's nominations to Crescent Point board

2018-04-20 reuters
(Reuters) - Proxy advisory firm Institutional Shareholder Services on Thursday recommended Crescent Point Energy Corp (CPG.TO) shareholders vote for activist investor Cation Capital’s four nominations to the oil and gas producer’s board.
Upvote Downvote

 
UPDATE 1-Petrobras gets three bids for gas pipeline network -sources

2018-04-19 reuters
SAO PAULO (Reuters) - Brazil’s state-controlled oil company Petroleo Brasileiro SA on Thursday received three binding bids for its gas pipeline network company TAG, three sources with knowledge of the matter said.
Upvote Downvote

 
FirstEnergy Solutions Bankruptcy Could Take a Long Time

2018-04-19 247wallst
When FirstEnergy Corp. (NYSE: FE) subsidiary FirstEnergy Solutions (FES) filed for bankruptcy on the last day of March, the engine started running on what could be a procedure that takes years to reach a conclusion.
Upvote Downvote

 
Long Blockchain Announces Stockholder Update; Executes on Milestones, Positions for Fintech-Distributed Ledger Technology Leadership

2018-04-19 globenewswire
Farmingdale, New York, April 19, 2018 (GLOBE NEWSWIRE) -- Long Blockchain Corp. (OTCPink: LBCC) (the “Company” or “LBCC”) made available today an update letter to stockholders. The full text of the letter is set forth below.
Upvote Downvote

 
EU mergers and takeovers (April 17)

2018-04-17 reuters
BRUSSELS, April 17 (Reuters) - The following are mergers under review by the European Commission and a brief guide to the EU merger process:
Upvote Downvote

 
EU mergers and takeovers (April 16)

2018-04-16 reuters
BRUSSELS, April 16 (Reuters) - The following are mergers under review by the European Commission and a brief guide to the EU merger process:
Upvote Downvote

 
MOVES-Macquarie Capital names European head of equity capital markets and corporate broking

2018-04-13 reuters
April 13 (Reuters) - Macquarie Capital, the principal investment arm of Australian investment bank Macquarie Group on Friday named Charles Lucas as a managing director and European head of equity capital markets and corporate broking.
Upvote Downvote

 
NAB's Mike Baird calls green energy 'tipping point'

2018-04-12 theage.com.au
Rapid growth in renewable energy investment has propelled the sector to a "tipping point," former NSW premier Mike Baird says, amid predictions investors will pour trillions of dollars globally into green electricity projects in the coming decades.
Upvote Downvote

 
NAB's Mike Baird calls green energy 'tipping point'

2018-04-12 smh.com.au
Rapid growth in renewable energy investment has propelled the sector to a "tipping point," former NSW premier Mike Baird says, amid predictions investors will pour trillions of dollars globally into green electricity projects in the coming decades.
Upvote Downvote

 
Xi’s conciliatory gesture raises guarded optimism amid U.S. trade war threat

2018-04-10 japantimes.co.jp
BEIJING – Investors and China watchers welcomed President Xi Jinping’s pledge Tuesday to open his country’s market wider to foreign competition, hoping it will ease a trade dispute with Washington that has unsettled financial markets and could jeopardize a global economic expansion.
Upvote Downvote

 
Stepping away from the 'abyss': Sharemarkets jump in response to Xi Jinping's speech

2018-04-10 theage.com.au
Investors and China watchers welcomed President Xi Jinping's pledge Tuesday to open his country's market wider to foreign competition, hoping it will ease a trade dispute with Washington that has unsettled financial markets and could jeopardise a global economic expansion.
Upvote Downvote

 
Stepping away from the 'abyss': Sharemarkets jump in response to Xi Jinping's speech

2018-04-10 smh.com.au
Investors and China watchers welcomed President Xi Jinping's pledge Tuesday to open his country's market wider to foreign competition, hoping it will ease a trade dispute with Washington that has unsettled financial markets and could jeopardise a global economic expansion.
Upvote Downvote

 
American Airlines Tumbles on Oil Price Worries - Bloomberg

2018-04-10 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Giant Wind Turbines Start to Pay Off and Investors Want More

2018-04-10 rigzone
(Bloomberg) -- The expanding network of giant windmills in the North Sea -- the largest such collection in the world -- is turning into a windfall for some bankers helping institutional investors acquire a piece of Europe’s renewable-energy market.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...